It is noteworthy that 7DW8-5 combined with a TLR4 agonist, monophosphoryl lipid A (MPLA), displays a potent adjuvant effect and enhances the levels of antigen-specific CD8+ T-cell responses with effector memory function and protective immunity to malaria and cancer35. The gene discussed is CD8A; the disease is malaria.